We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Central and Peripheral Venous Catheters

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00122707
First Posted: July 22, 2005
Last Update Posted: March 22, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Assistance Publique - Hôpitaux de Paris
  Purpose
The purpose of this study is to compare the mechanical and infectious complications of peripheral versus central venous catheters in critically ill patients. Group allocation will be performed by randomization.

Condition Intervention
Respiratory Insufficiency Shock Coma Device: catheters

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Randomized Controlled Trial of Mechanical and Infectious Complications of Central Versus Peripheral Venous Catheters in ICU Patients

Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • failure to insert line
  • mechanical complications of intravenous line insertion
  • infectious complications of intravenous lines

Secondary Outcome Measures:
  • number of cross-overs (due to impossibility of inserting/maintaining a peripheral line)

Estimated Enrollment: 300
Study Start Date: April 2004
Estimated Study Completion Date: October 2005
Detailed Description:
Critically ill patients require intravenous administration of fluids and drugs. This can be achieved via peripheral or central catheters. Each device is associated with both mechanical and infectious complications. Complications associated with central lines are judged to be more severe. Some patients actually require the insertion of a central line due to the venous toxicity of the drugs or to the necessity of making sure that the infusion is regularly administered (example: high dose catecholamine infusion). Some physicians believe that most Intensive Care Unit (ICU) patients should have a central venous line inserted, whereas others feel that some patients may receive active drugs via a peripheral line in selected instances. No study prospectively compared the feasibility, merits and complications of the two possibilities (i.e., central or peripheral venous line). This study includes patients that can receive either a central or a peripheral line (see inclusion criteria): mainly patients receiving large amounts of fluid, moderate doses of catecholamines or of drugs that may cause venous injury. Patients are randomized to receive either a peripheral or a central venous catheter. Endpoints are the rate of mechanical complications (difficulty in inserting the line, need for repeat insertion attempts, occurrence of arterial puncture, occurrence of pneumothorax) and of infectious complications (local catheter infection or catheter-related bloodstream infection).
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients requiring low to moderate doses of continuous catecholamine administration in the ICU
  • Patients with 2 failed attempts at inserting a peripheral line
  • Patients who require daily change of lines

Exclusion Criteria:

  • Patients aged less than 18 years
  • Pregnancy
  • Absolute necessity of central venous access (refractory shock/high dose catecholamine infusion)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00122707


Locations
France
Service de Réanimation, Hopital Louis Mourier
Colombes, France, 92700
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: Jean-Damien Ricard, MD Assistance Publique - Hôpitaux de Paris
  More Information

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00122707     History of Changes
Other Study ID Numbers: LMR1
First Submitted: July 19, 2005
First Posted: July 22, 2005
Last Update Posted: March 22, 2006
Last Verified: June 2005

Keywords provided by Assistance Publique - Hôpitaux de Paris:
catheter-related infection
mechanical complications of catheters

Additional relevant MeSH terms:
Respiratory Insufficiency
Pulmonary Valve Insufficiency
Respiration Disorders
Respiratory Tract Diseases
Heart Valve Diseases
Heart Diseases
Cardiovascular Diseases